Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jun 2017 for GENVEC INC, €5,114.
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
7
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stefan Loren: trading record in brief
This profile gathers the share dealings of Stefan Loren across 2 companies, led by Genvec Inc and Marina Biotech, Inc. The record holds 13 filings, for trades running from 1 January 2014 to 16 June 2017.
Every open-market trade on record is a purchase: 7 purchases worth €8,983, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise.
Half of the purchases are above €180 and half below.
The newest entry dates from 20 June 2017: a share grant of €5,067, in Genvec Inc. The most recent open-market purchase was published on 18 November 2015, 3,992 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stefan Loren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,500 shares@ US$3.80100.0% of flowCommon StockSEC:0001123292-17-001159:0
793 shares@ US$7.19Common StockSEC:0001123292-17-001159:1
1,207 sharesCommon StockSEC:0001123292-17-001159:2
3,600 shares@ US$1.93Common StockSEC:0001140361-15-042113:0
Canonical exit: 14 Feb 2016 (T+90)
100 shares@ US$1.93Common StockSEC:0001140361-15-042113:1
Canonical exit: 14 Feb 2016 (T+90)
100 shares@ US$2.06Common StockSEC:0001140361-15-030423:0
Canonical exit: 31 Mar 2015 (T+90)
900 shares@ US$2.16Common StockSEC:0001140361-15-030423:1
Canonical exit: 31 Mar 2015 (T+90)
100 shares@ US$2.06Common StockSEC:0001140361-15-000194:0
900 shares@ US$2.16Common StockSEC:0001140361-15-000194:1
181,303 sharesCommon StockSEC:0001571049-14-000037:0
10 of 10 declarations
